SGLT-2 Inhibitors Linked to Lower Epilepsy Risk in Type 2 Diabetes: Study Dr. Shravani Dali21 May 2025 9:15 AM ISTA recent population-based study published in Diabetes Care suggests that sodium-glucose cotransporter 2 (SGLT-2) inhibitors, commonly prescribed for...
SGLT2 Inhibitors and GLP-1 Receptor Agonists Linked to Fewer COPD Exacerbations in diabetes patients with COPD: JAMA Dr Riya Dave17 Feb 2025 8:45 AM ISTResearchers had found in a new study that sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists...
DPP-4 inhibitors may Reduce Osteoporosis Risk among Diabetes patients Dr. Shravani Dali27 Dec 2023 11:00 AM ISTDPP-4 inhibitors may Significantly improve BMD and Reduce Osteoporosis Risk in Diabetes patients suggests a new study published in the Journal of...
Use of SGLT2 inhibitors tied to lower dementia risk in older people with type 2 diabetes: Study Medha Baranwal3 Jan 2023 11:45 AM ISTCanada: The new use of sodium-glucose cotransporter-2 (SGLT2) inhibitors compared with dipeptidyl peptidase 4 (DPP-4) inhibitors confers 20% lower...
Teneligliptin lowers blood sugar in type 2 diabetes without prolonging QT/QTc interval: JAPI Dr. Hiral patel5 July 2022 10:15 AM ISTIndia: A novel drug, teneligliptin helps achieve targeted glycemic control in patients with type 2 diabetes mellitus (T2DM) without prolonging the...
GLP 1 Receptor Agonists to have better outcomes Than DPP4 Inhibitors Dr. Nandita Mohan14 March 2022 5:00 PM ISTA recent study suggests that the use of GLP-1 receptor agonists was associated with better outcomes compared with the use of DPP-4 inhibitors among...
Insulin Glargine Induces Less Insulin Antibody Than Other Insulin Regimens MD Bureau11 March 2022 10:00 AM ISTInsulin antibodies (IAs), which were found commonly developed in patients treated with exogenous insulin, might affect glycemic control due to their...
GLP-1 Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD Dr Kartikeya Kohli10 March 2022 10:30 AM ISTChronic kidney disease (CKD) and end-stage kidney disease (ESKD) are contributors to the health burden and are associated with increased mortality and...
SGLT2i tied to lower mortality and better outcomes than DPP4i, finds Study Medha Baranwal7 Sept 2021 10:15 AM ISTItaly: Initiation of SGLT2 inhibitors under routine care versus initiation of DPP4 inhibitors leads to better cardiorenal outcomes and lower mortality...
Use of DPP-4 inhibitors tied to lower risk of Alzheimer's disease in diabetes patients: Study Hina Zahid13 Aug 2021 10:30 AM ISTResults showed less amyloid in the brains of people taking these medications and less cognitive decline, when compared to people without...
DPP-4 inhibitors and SGLT2 inhibitors effective in diabetics after kidney transplant Medha Baranwal26 Dec 2020 12:30 PM ISTGreece:Evidence regarding the utilization of DPP-4 inhibitors and particularly SGLT2 inhibitors and GLP-1 receptor agonists is limited in renal...
Dapagliflozin Going Off Patent with a Slashed Price Hina Zahid3 Nov 2020 11:30 AM ISTDiabetes is well-known to adversely impact the heart, vascular system and renal system. The patients with type 2 diabetes mellitus (T2DM) are at...
